We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Dr Nimish Shah at Spire include:
I am a Consultant Haematologist based at Norfolk and Norwich University Hospital. I have a high degree of expertise in treating haematological cancers, such as lymphoma and chronic leukemia. I specialise in the management of lymphoma and chronic leukemia.
I have a specific interest in haematology clinical trials and represent the East of England NCRN clinical trials subgroup for lymphoma and hematological cancers. I am also an investigator in numerous haematology clinical trials at Norfolk and Norwich University Hospital. This is an important part of my work as hopefully this will lead to better and improved treatment for patients.
I qualified from University College Dublin Medical School and undertook my postgraduate training in the East and South West of England. I successfully completed my Masters Degree in Lymphoma in 2012, while I was a Clinical Research Fellow at Derriford Hospital, Haematology Clinical Trials Unit, Plymouth and University of Plymouth, Medical School.
MbbCH BAO / University College Dublin, Ireland / 2002
Bachelor of Medicine, Bachelor of Surgery, Bachelor of Obstetrics
Degree qualification in medicine, surgery and obstetrics.
Masters Degree in Lymphoma / University of Plymouth Medical School / 2012
Specialist qualification in the study of lymphoma. Completing a research project in Mantle Cell Lymphoma.
Norfolk & Norwich University Hospital.Back to top
I enjoy cricket and play for my local club. I also enjoy the outdoors and spend time with my family hiking, camping and traveling.Back to top
|Telephone||01603 286 899|
|Private secretary||Mollie Sutton|
11 February 2020
Redbridge-based Spire London East Hospital has been upgraded to a ‘Good’ rating following an inspection by the Care Qual…
04 February 2020
The Paterson Independent Inquiry published its final report on 4 February 2020.